18 01, 2022

Chemoprophylaxis against COVID-19 among health-care workers using Ivermectin in low- and middle-income countries: A systematic review and meta-analysis

January 18, 2022|Ivermectin, Vax Damage|

Abstract

Coronavirus disease-2019 (COVID-19) is a novel viral infectious disease that the World Health Organization (WHO) has announced to be a pandemic. This meta-analysis was aimed at providing evidence for the use of ivermectin to prevent COVID-19 among hospital workers in low-resource countries.

Medical databases […]

16 01, 2022

Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching

January 16, 2022|Ivermectin, Research, World|

Abstract

Background: Ivermectin has demonstrated different mechanisms of action that potentially protect from both coronavirus disease 2019 (COVID-19) infection and COVID-19-related comorbidities. Based on the studies suggesting efficacy in prophylaxis combined with the known safety profile of ivermectin, a citywide prevention program using ivermectin for COVID-19 was implemented […]

13 01, 2022

Truth, Lies and COVID Treatment

January 13, 2022|Doctors, Ivermectin, World|

Two Southern California doctors caught the FDA, CDC, and NIH in a big fat lie. They did a study involving 7,000 of their own patients.

While the official position has been that there is no effective early outpatient […]

30 11, 2021

Retrospective Statistical Analysis Indicates Ivermectin a COVID-19 Stopper in Africa

November 30, 2021|Ivermectin, Research, World|

Africa stands out in the world for its relatively mild effect from COVID-19. Theories as to why this is the case are multiple running the gamut from underreporting and lack of testing to youthful population and genetic predisposition and even the wide use of ivermectin in numerous countries.

Thus far scientists haven’t been able to explain […]